Ono will gain access to Deciphera’s kinase inhibitor pipeline, which includes the CSF-1 inhibitor vimseltinib and ULK ...

AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic ...

The AHF Global Public Health Institute has voiced concerns over the World Health Organization’s (WHO) proposed pandemic ...

The expanded approval of Biktarvy was based on the Phase I trial data showing efficacy in pregnant HIV-positive individuals.

Familial adenomatous polyposis (FAP) can lead to polyps in the colon and/or rectum which can lead to cancer if not removed.

Clinical trials across the globe are investigating new treatments for Duchenne Muscular Dystrophy, improving muscular and ...

PharmaLink has partnered with Recall Results for accurate and responsive drug recalls, withdrawals and market actions in the ...

Sino Biological has concluded the acquisition of SignalChem Biotech (SCB) for $48m, expanding its portfolio and global ...

Experts hold scalability challenges and high costs accountable for market failures within the cell and gene therapy landscape ...

The US Food and Drug Administration (FDA) has approved Utility Therapeutics’ Pivya tablets, a new treatment for female adults ...

AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn reported ...

Health Canada has approved Merck & Co Inc (MSD)’s Keytruda (pembrolizumab), an anti-programmed cell death protein 1 (PD-1) ...